|

autologous HSCs Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • University of Florida1

Indications

  • Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma1
  • Recurrent Group 3 Medulloblastoma1
  • Cancer1

Gainesville, Florida1 trial

Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma

University of Florida Health

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.